Common mistakes that can delay FDA 510(k) reviews As

New Post Public Reply Private Reply Replies (0) Message Board
trtruth10
Common mistakes that can delay FDA 510(k) reviews

As discussed, there are two places where the 510(k) process can come to a halt. The first is the RTA process: an RTA is used when a submission does not contain all of the required information - for example, if electrical safety test data is required, but was not submitted. This can result in a significant delay. The other major impact to the successful clearance of your 510(k) is the AI Letter. Common issues that may result in an AI include:


Inadequate device description

All 510(k) submissions must include accurate descriptions of how the device is intended to function. An incomplete or inaccurate description will prevent FDA reviewers from determining if your device has been properly evaluated; reviewers will also be unable to determine if your documentation supports your device’s intended use. You must include a thorough and accurate description of your device to ensure a substantive FDA review of your 510(k) submission. Many devices, particularly those containing electronics require a very thorough and detailed technical description of how the device operates. For some devices, these requirements may be defined in a Guidance Document.


Discrepancies throughout submission

510(k) submissions are highly redundant – the same information appears in multiple sections throughout the document. Repeating this information may assist the FDA when they divide the submission among various sub-reviewers. Nonetheless, it is important to be consistent in these redundant sections.
Assure the Indications for Use is exactly the same every time it appears in the submission. Even a small discrepancy can trigger a RTA letter. As previously mentioned, your device should have the exact same indications for use as your predicate device or any differences should be very minor.Without a consistent Indications for Use statement, FDA reviewers cannot determine if you used appropriate methods to evaluate your device’s performance to support your intended use claims. Additionally, assure the standards listed are consistent throughout the document, that the predicates listed are consistent, etc.


Product name

The product name is likely to occur a hundred times throughout the submission, so ensure it is consistent throughout the documentation.


Failure to follow or address guidance documents or standards

In order to help medical device manufacturers determine what to include in their 510(k) applications, the FDA issues guidance documents or defers to national or international standards. Failure to follow current guidance or meet relevant standards for your device, without explaining why in your 510(k) submission, often results in an AI from the FDA. As mentioned above, these guidance documents may not have been updated recently and the standards cited may no longer be current.


Inadequate or missing performance testing data

All traditional 510(k) submissions must include performance testing data. FDA reviewers cannot determine substantial equivalence between your device and its predicate device without performance testing.



Usability report

Usability reports are an issue when the testing was not conducted as described in the guidance document. The sample size may have been too small, testing may not have included the how user will select the device (for OTC), etc.


Risk Management

The consensus standard for risk management in the US is ISO 14971:2007. It requires a Risk Management Plan, a Risk Management Analysis, and a Risk Management Summary Report. The analysis is frequently a Failure Modes and Effect Analysis (FMEA) – but other tools are also acceptable – and must be submitted with the 510(k). Risk Analysis is a complex, time-consuming team activity. Allow plenty of time to complete this process and documentation before finalizing the 510(k) submission.

Missing clinical data and forms

For some device types, 510(k) submissions must include clinical performance data in order to evaluate substantial equivalence. If clinical data is submitted, there are forms that document if the investigator had any financial relationship with the sponsor, as well as the ClinicalTrials.gov form, are required. Note that if clinical data is not submitted, these forms are no longer required.

Medifirst Solutions Inc. (MFST) Stock Research Links

MFST Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Implantica's U.S. Launch Arrives With Cash Still to Burn

Updated Category News Views 0

RefluxStop has finally stepped onto American soil, and that changes the conversation around Implantica in a very real way. FDA Premarket Approval arrived on August 20, then the first U.S. procedures were completed in early November at the University of Southern California. For a small medtech outfit, clearing that regulatory gate and getting actual patients treated are...

Continue Reading
Nellie's 50% Booking Jump Reveals a Quieter Luxury

Updated Category News Views 141

Silicon Valley’s rich are apparently tired of performing wealth for strangers, and frankly, that tracks. Nellie’s 2027 forecast says its mostly tech-money clientele is moving past the old trophy case of private jets, famous resort towns, and suites priced like small houses. The prize now is privacy, a clean schedule, and somebody competent fixing the ugly little...

Continue Reading
Hyundai’s Third SUV Crown Matters Beyond the Trophy

Updated Category News Views 0

A Three-Year Streak Is Not Just Decorative Three straight SUV-brand wins can make even a cynical car watcher pause. Hyundai has been named U.S. News & World Report’s 2027 Best SUV Brand after editors assessed vehicles from 39 brands, and that is a useful bit of outside validation in a segment where nearly everybody is throwing sheet metal, screens, and marketing dollars...

Continue Reading
NextPatient’s KLAS Marks Signal Specialty Workflow Fit

Updated Category News Views 79

A 93.3 score in healthcare software deserves a second look. Not a victory lap, not a drumroll—just a serious look at whether the product is solving an annoying, expensive operational problem for specialty practices. NextPatient’s recognition in the 2026 KLAS Emerging Solutions Top 20 Report lands in that category. The company placed in the top five for improving...

Continue Reading
illumine Targets Childcare Chain Control and Risk Gaps

Updated Category News Views 131

Expansion Gets Messy Before It Gets Impressive Childcare operators do not usually stumble because they forgot how to care for children; they stumble because the back office fractures as the network grows. One center handles fees one way, another lets enrollment leads work a different funnel, and headquarters discovers too late that its reports are arguing with each other....

Continue Reading
Rehab Equipment Growth Meets a Brutal Access Gap

Updated Category News Views 151

Rehabilitation demand is piling up faster than the equipment can reach people. That is the uncomfortable fact sitting beneath Wissen Research's forecast for a global rehabilitation equipment market rising from $19.1 billion in 2026 to $25.8 billion by 2031, a 6.2% annual growth rate. It is a respectable expansion story, not some rocket-ship fairy tale. More important, it...

Continue Reading
Sinopec's Green Fuel Push Meets a Hard Reality Check

Updated Category News Views 30

A refinery giant talking about green jet fuel at a climate summit is exactly the sort of thing that makes old energy hands squint first—and then check the asset list. Sinopec did bring more than lofty language to its Nov. 16 COP31 side event in Antalya: it brought long-range energy forecasts, named fuel-production routes, hydrogen infrastructure and operating projects....

Continue Reading
Yatsen’s November 25 Report Is the Real Beauty Test

Updated Category News Views 90

Beauty shelves can hide a lot of sins, but earnings day tends to drag them into fluorescent light. Yatsen will release unaudited third-quarter 2026 financial results before the U.S. market opens on Wednesday, November 25, then management will take questions at 7:30 a.m. Eastern Time. For anyone following NYSE:YSG, this is not a results story yet. It is a calendar marker,...

Continue Reading
Dutch Solar Homes Face a 2027 Net Metering Reset Ahead

Updated Category News Views 24

A policy switch buried in a Dutch calendar is about to rearrange millions of kitchen-table energy calculations. On 1 January 2027, the Netherlands ends net metering, or salderingsregeling, and households with solar panels will no longer offset exported power against electricity bought from the grid. That is not some abstract regulatory footnote. It changes the value of...

Continue Reading
Misunderstood Brands Bets Small Cans Can Scale Growth

Updated Category News Views 190

A tiny cocktail can is a brutal little test of whether a spirits brand has legs. Misunderstood Brands is putting four 100mL offerings on the shelf just as its Wegmans distribution expands across the East Coast, and that combination matters more than another glossy flavor announcement. The company is trying to turn products people discovered in bars and restaurants into...

Continue Reading

Top 5 Most Recently Viewed Articles

Sought-After Bourbons to Shine at Art of Bourbon Auction

Updated Category News Views 227

Discover Rare Bourbons at the Upcoming Art of Bourbon Auction On September 12, the Speed Art Museum will host a remarkable auction featuring some of the rarest and most coveted bourbons in the world. This event is sure to attract bourbon lovers and collectors, offering a unique chance to bid on exclusive whiskey selections. Event Details and Ticket Information The live...

Continue Reading
Forbright Bank Celebrated as Leader in Eco-Friendly Banking

Updated Category News Views 258

Forbright Bank Recognized for Environmental Excellence Forbright Bank has proudly received the prestigious title of Best Eco-Friendly Bank in America by Bankrate. This accolade, part of Bankrate’s Best Products in Personal Finance Awards, highlights Forbright Bank's unwavering dedication to sustainability and responsible lending practices. Notably, this award is making...

Continue Reading
Massimo Group Introduces Exciting New UTV Models for Enthusiasts

Updated Category News Views 183

Massimo Group Expands UTV Lineup with the Buck 450 and T-Boss 900L Crew Massimo Group (NASDAQ: MAMO), a prominent manufacturer and distributor of powersports vehicles, is rolling out two exciting additions to its UTV lineup: the Buck 450 4WD UTV and the T-Boss 900L Crew UTV. These new models aim to enhance the company's offerings and strengthen collaborations with retail...

Continue Reading
LightBox CRE Index Shows Remarkable Growth Amid Policy Changes

Updated Category News Views 186

The Rise of the LightBox CRE Activity Index Successful trends in the commercial real estate (CRE) market are significantly highlighted by the recent surge in the LightBox CRE Activity Index. The index recorded a remarkable increase to 96.1 in February, marking an impressive rise from 80.7 in January and 75.8 a year ago. This surge points to a 19% month-over-month and 27%...

Continue Reading
D/Quarters Expands to Meet Rising Demand at Dubai Science Park

Updated Category News Views 180

D/Quarters Expands to Meet Rising Demand at Dubai Science Park D/Quarters, a leading provider of high-quality co-working spaces from TECOM Group PJSC, is expanding its footprint in Dubai Science Park, doubling the size of its offices. This decision arises from the increasing demand for versatile workspaces amid the city's dynamic business landscape. Growing Demand for...

Continue Reading